JP Morgan Chase’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
JP Morgan Chase's DXCM Position: Q2 2026 in Review
JP Morgan Chase reduced its DexCom (DXCM) stake by 45% in Q2 2026, selling an estimated $178M and leaving 3,325,095 shares worth $233M. The position accounts for 0.01% of the portfolio, ranked #696.
JP Morgan Chase first reported a position in DXCM in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.64B in Q3 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- JP Morgan Chase held 3,325,095 shares of DexCom worth $233M as of Q2 2026.
- JP Morgan Chase sold 2,674,375 DexCom shares in Q2 2026, an estimated $178M.
- DexCom made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #696 holding.
- JP Morgan Chase first reported a position in DexCom in Q2 2013 and has held it in 51 quarters since.
- JP Morgan Chase's DexCom position peaked at $1.64B in Q3 2021.
- 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.